IT1254706B - Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale - Google Patents

Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale

Info

Publication number
IT1254706B
IT1254706B ITPD910234A ITPD910234A IT1254706B IT 1254706 B IT1254706 B IT 1254706B IT PD910234 A ITPD910234 A IT PD910234A IT PD910234 A ITPD910234 A IT PD910234A IT 1254706 B IT1254706 B IT 1254706B
Authority
IT
Italy
Prior art keywords
ganglioside
spinal cord
treatment
damage
therapeutic use
Prior art date
Application number
ITPD910234A
Other languages
English (en)
Inventor
Gino Toffano
Alberta Leon
Marino Massarotti
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITPD910234A priority Critical patent/IT1254706B/it
Publication of ITPD910234A0 publication Critical patent/ITPD910234A0/it
Priority to EP91122324A priority patent/EP0548406A1/en
Publication of ITPD910234A1 publication Critical patent/ITPD910234A1/it
Application granted granted Critical
Publication of IT1254706B publication Critical patent/IT1254706B/it
Priority to US10/125,810 priority patent/US6620793B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invenzione si riferisce ad un metodo per il recupero neurologico di pazienti con danno al midollo spinale tramite la somministrazione del ganglioside GM1. Un ulteriore oggetto della presente invenzione è una terapia associata per il trattamento del danno al midollo spinale, rappresentata dalla somministrazione del ganglioside GM1 e dei farmaci presunti attivi per il sopracitato trattamento, ed in modo preferenziale del metilprednisolone.
ITPD910234A 1991-12-23 1991-12-23 Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale IT1254706B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITPD910234A IT1254706B (it) 1991-12-23 1991-12-23 Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale
EP91122324A EP0548406A1 (en) 1991-12-23 1991-12-27 Therapeutic use of ganglioside GM1 in the treatment of spinal cord injury
US10/125,810 US6620793B2 (en) 1991-12-23 2002-04-18 Therapeutic use of ganglioside GM1 in the treatment of spinal cord injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD910234A IT1254706B (it) 1991-12-23 1991-12-23 Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale

Publications (3)

Publication Number Publication Date
ITPD910234A0 ITPD910234A0 (it) 1991-12-23
ITPD910234A1 ITPD910234A1 (it) 1993-06-23
IT1254706B true IT1254706B (it) 1995-10-09

Family

ID=11389754

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD910234A IT1254706B (it) 1991-12-23 1991-12-23 Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale

Country Status (3)

Country Link
US (1) US6620793B2 (it)
EP (1) EP0548406A1 (it)
IT (1) IT1254706B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258310B (it) * 1992-04-10 1996-02-22 Fidia Spa Composizioni farmaceutiche comprendenti derivati monosialogangliosidici atte al trattamento del danno al midollo spinale.
US6888807B2 (en) * 2002-06-10 2005-05-03 Ipr Licensing, Inc. Applying session services based on packet flows
US20070004625A1 (en) * 2005-06-30 2007-01-04 Li Liang-Man Use of complement inhibitory proteins to treat spinal cord injury
EP1738763A1 (en) 2005-06-30 2007-01-03 AVANT Immunotherapeutics, Inc. Use of complement inhibitory proteins to treat spinal cord injury
US7943750B2 (en) * 2007-06-18 2011-05-17 Laboratoire Medidom S.A. Process for obtaining pure monosialoganglioside GM1 for medical use
ES2750308T3 (es) * 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
SE8703625D0 (sv) 1987-09-18 1987-09-18 Kabivitrum Ab New medical use

Also Published As

Publication number Publication date
US20030153517A1 (en) 2003-08-14
ITPD910234A1 (it) 1993-06-23
EP0548406A1 (en) 1993-06-30
ITPD910234A0 (it) 1991-12-23
US6620793B2 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
Meissner Treatment of patients in the borderline spectrum.
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
FI972554A0 (fi) Hiukkasten antomuoto
DK0522092T3 (da) Iontophoretisk medikamentindgiftssystem med to-trins-indgiftsprofil
ES2000428A4 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
EP1019072A4 (en) ASSISTANCE PROCESS FOR DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISM SYNDROME
GR76810B (it)
EP0962225A3 (en) Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
ES2172510T3 (es) Nueva combinacion de formoterol y budesonida.
MD413G2 (ro) Lampă de lumină polarizată pentru terapia de biostimulare
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
EE03265B1 (et) Valu vaigistavad opioidpeptiidid ja nende kasutamine
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
ES2153519T3 (es) Anestesico local para la terapia topica de dolores de espalda y distension muscular.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
IT1254706B (it) Uso terapeutico del ganglioside gm1 nel trattamento del danno al midollo spinale
DK505584A (da) Administrationssaet og farmaceutiske praeparater til anvendelse dertil
IT8367651A0 (it) Dispositivo infusore medico impiantabile nel corpo del paziente
Shepley et al. Treatment by Electrically Induced Convulsions
ES2137172T3 (es) Vacunas antitumorales que comprenden celulas transfectadas con il-6.
Wolpow Brachial plexus neuropathy: Association with desensitizing antiallergy injections
ES2071977T3 (es) Uso de interferon gamma para la fabricacion de un medicamento en el tratamiento del asma dependiente de esteroides.
AU7323187A (en) Portable electro-therapy system

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981002